Oxytocin effects in schizophrenia: reconciling mixed findings and moving forward

ER Bradley, JD Woolley - Neuroscience & Biobehavioral Reviews, 2017 - Elsevier
Schizophrenia is a severe mental illness that causes major functional impairment. Current
pharmacologic treatments are inadequate, particularly for addressing negative and cognitive …

Perspectives on the Positive and Negative Syndrome Scale (PANSS): Use, misuse, drawbacks, and a new alternative for schizophrenia research.

A Aboraya, HA Nasrallah - … of Clinical Psychiatry: Official Journal of …, 2016 - europepmc.org
Background In 1987, Kay et al published the Positive and Negative Syndrome Scale
(PANSS) and the PANSS manual to address the limitations of existing instruments for …

Altered gut microbiota and its metabolites correlate with plasma cytokines in schizophrenia inpatients with aggression

H Deng, L He, C Wang, T Zhang, H Guo, H Zhang… - BMC psychiatry, 2022 - Springer
Background The pathophysiological mechanisms of aggression are manifold and they may
closely interconnect. Current study aimed to determine the gut microbiota and its …

A multinational case− control study comparing forensic and non-forensic patients with schizophrenia spectrum disorders: the EU-VIORMED project

G de Girolamo, L Iozzino, C Ferrari, P Gosek… - Psychological …, 2023 - cambridge.org
Background The relationship between schizophrenia and violence is complex. The aim of
this multicentre case–control study was to examine and compare the characteristics of a …

Illness management and recovery: one-year follow-up of a randomized controlled trial in Danish community mental health centers: long-term effects on clinical and …

SB Jensen, HS Dalum, L Korsbek, C Hjorthøj… - BMC psychiatry, 2019 - Springer
Abstract Background: Illness Management and Recovery (IMR) is a curriculum-based
rehabilitation program for people with severe mental illness with the short-term aim of …

Genetic contribution of synapse-associated protein 97 to cerebellar functional connectivity changes in first-episode schizophrenia

X Xu, S Luo, X Wang, X Wen, J Yin, X Luo, B He… - BMC psychiatry, 2023 - Springer
Our previous study data suggested that the synapse-associated protein 97 (SAP97)
rs3915512 polymorphism is significantly related to clinical performance in schizophrenia …

[HTML][HTML] Are shorter versions of the positive and negative syndrome scale (PANSS) doable? A critical review

JP Lindenmayer - Innovations in Clinical Neuroscience, 2017 - ncbi.nlm.nih.gov
Abstract The Positive and Negative Syndrome Scale (PANSS) is a well-established
assessment tool for measuring symptom severity in schizophrenia. Researchers and …

Patterns of schizophrenia symptoms: hidden structure in the PANSS questionnaire

J Lefort-Besnard, G Varoquaux, B Derntl… - Translational …, 2018 - nature.com
The clinical presentation of patients with schizophrenia has long been described to be very
heterogeneous. Coherent symptom profiles can probably be directly derived from behavioral …

[HTML][HTML] A schizophrenia-like behavioral trait in the SHR model: Applying confirmatory factor analysis as a new statistical tool

FF Peres, RÁ Eufrásio, DA Gouvêa, MC Diana… - Progress in Neuro …, 2018 - Elsevier
Questionnaires that assess symptoms of schizophrenia patients undergo strict statistical
validation, often using confirmatory factor analysis (CFA). CFA allows testing the existence of …

Positive and negative syndrome scale in forensic patients with schizophrenia spectrum disorders: a systematic review and meta-analysis

C Buizza, C Strozza, G Sbravati, G de Girolamo… - Annals of General …, 2022 - Springer
Among forensic patients with schizophrenia spectrum disorders, the association between
symptomatology and violence is still not entirely clear in literature, especially because …